Diastolic blood pressure achieved at target systolic blood pressure (120–140 mm Hg) and dabigatran-related bleeding in patients with nonvalvular atrial fibrillation: A real-world study

OBJECTIVE: Elevated systolic blood pressure (SBP) can significantly increase the bleeding risk in patients with atrial fibrillation (AF). However, it is unclear whether elevated diastolic blood pressure (DBP), in the presence of well-controlled SBP is also associated with bleeding. Therefore, we aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yu, Li, Minghui, Zhou, Wei, Wang, Tao, Zhu, Lingjuan, Hu, Lihua, Bao, Huihui, Cheng, Xiaoshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585965/
https://www.ncbi.nlm.nih.gov/pubmed/33001045
http://dx.doi.org/10.14744/AnatolJCardiol.2020.11823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585965/
https://www.ncbi.nlm.nih.gov/pubmed/33001045
http://dx.doi.org/10.14744/AnatolJCardiol.2020.11823

Ejemplares similares